29-Oct-2026 22:37:25
SUDARSHANGeneral news
SUDARSHAN PHARMA INDUSTRIES Q2 FY27 (CONS.) ; NET PROFIT UP 100.91% AT ₹7.78 CR (YOY), UP 38.70% (QOQ)
REVENUE UP 28.49% AT ₹216.97 CR (YOY), UP 24.40% (QOQ) EBITDA UP 117.10% AT ₹19.98 CR (YOY), UP 25.67% (QOQ) MARGINS AT 9.21% VS 5.45% (YOY), 9.12% (QOQ)
SUDARSHAN PHARMA IND LTD